Bullboard - Stock Discussion Forum Avisa Diagnostics Inc FOGCF

Avisa Diagnostics Inc. is a clinical-stage medical device company. The Company is engaged in the development of the Allora BreathTest (ABT), a drug/device biomarker technology platform. The Allora BreathTest (ABT) is an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of bacterial load. ABT enables the ultra-rapid detection of virulent bacterial pathogens... see more

Add To Watchlist

GREY:FOGCF - Post Discussion

Avisa Diagnostics Inc > Post consolidation

View:

Post by Mcgirt on Feb 02, 2021 5:21pm

Post consolidation

Well, there will be 5,225,000 post consolidation shares of FOG plus the 33,263,123 common shares and 14,825,786 restricted voting shares issued to Avisa. Total outstanding for the new company will be 53,313,000 shares.

What will this technology be valued at? It's hard to value the current Avisa as it is private and its technology is considered novel. What would the market cap be?

179

Comment

Comment by sawrie on Feb 02, 2021 9:34pm

governments want reliable rapid tests to help prevent this virus from spreading and will eat this up ife it is proven effective. The sky is the limit and that is probably why avista is wanting to have a fast track to being a public company: so that they can capitalize on this opportunity before it passes. Money will be thrown at this company to have an opportunity to have a piece of this ...more

Comment